Embolotherapy Market
Embolotherapy Market Analysis, By Product Type (Embolic Agents, Support Devices), By Disease Indication (Cancer, Peripheral Vascular Disease, Peripheral Vascular Disease, Gastrointestinal Disorder, Urological & Nephrological Disorder, Others), By Procedure, End-user & Region - Global Market Insights 2022 to 2032
Analysis of Embolotherapy Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Embolotherapy Market Outlook (2022 to 2032)
The global embolotherapy market is currently valued at US$ 3,545.56 Million and is anticipated to expand at a CAGR of 8.4% to reach US$ 7,942.8 Million by 2032-end. The market is expected to witness growth owing to the increasing prevalence of cancer and more focus of the key players on technological advancements.
Increasing spending on the development of healthcare infrastructure particularly in the developing nations and increasing application in end-use industries are likely to drive the growth of the embolotherapy market in the forecast period. Embolization is a minimally invasive endovascular procedure used to deliberately stop blood flow in blood vessels when treating cancers, internal haemorrhages, aneurysms, and venous diseases.
| Report Attributes | Details |
|---|---|
| Expected Market Value (2022) | US$ 3,545.5 Billion |
| Projected Forecast Value (2032) | US$ 7,942.8 Billion |
| Global Growth Rate (2022 to 2032) | 8.4% CAGR |
| Key Companies Profiled | Medtronic Plc.; Stryker Corporation; Johnson & Johnson; BTG Plc.; Cook Medical; Penumbra Inc.; Abbott Laboratories; Boston Scientific Corporation; Merit Medical Systems; Terumo Corporation |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Embolotherapy Market Revenue Analysis 2017 to 2021 vs. Future Outlook 2022 to 2032
A sedentary lifestyle resulting in obesity and other cardiovascular diseases such as heart attack, stroke, Ischemic Heart Diseases (IHD), etc., are primarily driving the embolotherapy market. At the same time, embolotherapy procedures are anticipated to register a downturn, owing to increasing preference for treating COVID-19 patients.
Due to a reduction in both the supply and demand for the associated products, COVID 19 negatively affects the embolotherapy market However, complications arising out of COVID-19 infections are prioritized, thus sustaining growth of market.
As per market research and competitive intelligence provider Fact.MR, the market for embolotherapy witnessed a 7.9 % CAGR from 2017 to 2021. According to the latest analysis and report published by Fact.MR, the demand for embolotherapy market is likely to grow at a steady pace between 2022 to 2032. Sensing the opportunities, key players are relying on innovations, sustainability, and product development to gain a major share in the market.
What Market Trends Are Influencing Embolotherapy Market?
Technological advancement in healthcare propels the market growth
The demand for the global market for embolotherapy is anticipated to grow on account of the increasing incidence of several types of hepatic cancer and the increasing demand for minimally invasive procedures.
The increasing number of patients suffering from hepatic cell carcinoma (HCC), varicose veins, renal cell carcinoma (RCC), and aneurysms is rising, thereby leading to an increased mortality rate to drive the embolotherapy market growth.
Moreover, the increasing expenditure to improve healthcare infrastructure and the growing research and development activities for technological advancements in the healthcare sector is expected to drive growth of embolotherapy market.
Availability of a wide range of products and increase prevalence of cancer to drive the market growth
The process of embolotherpy is done with different products and ranges of devices. The availability of large number of products in global embolotherapy market has aided the market growth. Microspheres, embolic coils, embolic plugs are some the products used in embolotherapy.
Also the rising prevalence of various chronic diseases, such as cancer, are anticipated to boost the global embolotherapy market over the forecast period. For instance, according to Centre of Disease Control (CDC) Each year in the United States, about 25,000 men and 11,000 women get liver cancer, and about 19,000 men and 9,000 women die from the disease.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What are the Factors Hampering the Global Embolotherapy Market?
Although the embolotherapy market has numerous end-uses, there are some obstacles that likely pose a challenge to market growth during the forecasting. Rigid regulatory guidelines for devices used in embolotherapy systems, combined with the high cost of the procedure, are expected to limit the global embolotherapy market's growth.
The lack of skilled medical professionals and lack of some side effects associated with the emboli-removal catheter is the factor limiting the growth of the global embolotherapy market.
Country-wise Analysis
How will North America Perform in the Global Embolotherapy Industry Landscape?
Presence of an advanced healthcare sector in the region to propels the market growth
Globally, North America is anticipated to be the major regional market for embolotherapy market. Aggressive healthcare investment coupled with a high number of cardiovascular patients in the world is going to drive the regional embolotherapy market. According to Fact.MR, demand for embolotherapy in North America is likely to expand at an 8.1% value CAGR until 2032
Besides, the presence of large and global embolotherpay product manufacturers with contribute significantly to the growth of embolization market in the region. Because of higher technological advancement and recent FDA approvals for WEB systems, North America is expected to be the dominant market in the global embolotherapy market during the forecast period.
Embolotherapy market is anticipated to witness a healthy growth in the market due to growing number of ASCs (ambulatory surgery center) and increasing geriatric population in the US and Canada.
As per the U.S. department of health and human services, Ambulatory surgery has shown to be popular amongst both patients and physicians and the amount of Medicare certified ambulatory surgery centers has risen steadily all these factor drive the market growth in the region. Favorable reimbursement policies and up gradation in the compensation for the patients is North America is projected to drive demand for embolotherapy market in North America over the forecast period.
Why is Europe emerging as an Opportunistic Embolotherapy market?
Technological advancement in healthcare to drive the embolotherapy market in Europe
Europe is anticipated to be the second leading region for the market with a CAGR of 8.0%. The European market is set to witness gradual growth mainly because of the growing prevalence & incidence of cancer; the availability of treatment and increasing awareness regarding overall health.
The increasing cases of cardiovascular disorders in European countries such as the U.K., Germany, and Italy is expected to boost the embolotherapy market. Also, well-established reimbursement policies by private and public organizations is a major factor boosting the adoption of these therapies in the region.
How is Asia Pacific Contributing to the Growth of the Embolotherapy Market?
Increasing prevalence of cardiovascular diseases in the Asia Pacific to boost the market growth
According to Future Market Insights, Asia Pacific is expected to provide immense growth opportunities for the embolotherapy market. Extensive applications in the health industry are keeping sales of the embolotherapy market afloat across the region.
The growth of the market in Asia pacific is attributed to high population and increasing incidence of cardiovascular diseases in these regions along with growing per capita healthcare expenditure in countries like India and China.
Embolotherapy market is expected to increase significantly owing to the rise in cancer incidence rate and manufacturers focusing on expansion strategies in this regions. Increasing number of research activities regulated by various academic research academies further propels the global market growth.
Country-wise Forecast CAGRs for the Embolotherapy Market
| Country | CAGR |
|---|---|
| U.K | 8.0% |
| India | 7.9% |
| South Korea | 7.6% |
| China | 7.8% |
| U.S | 8.1% |
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Insights
By Product Type which segment generates high revenue in the Embolotherapy Market?
Embolic Agents to be Highly Sought After
Based on product embolotherapy market is segmented into embolic agent and support devices. The embolic agent segment further divided into Microspheres, Embolic coils, Embolic Plug Systems, Detachable Ballons, Liquid Embolic Agents, others. The segment is projected to grow at a CAGR of 7.5% through 2022 to 2032.
Embolic agents hold the highest share of the embolotherapy market dusting the forecast period. the growth of the segment is due to increase in use of embolic agents in different procedures and advancement in embolic agents.
Based on the End-user which is the most prominent segment in the embolotherapy market?
Hospitals & Clinics segment generates high revenue in the embolotherapy market
Based on the end-user embolotherapy market is segmented into hospitals, & Clinics, ambulatory surgical centres, and others, among all these the hospitals & clinics segment, holds the largest share of the market.
Increased adoption of minimally invasive procedures to drive the segment growth during the forecast period. Hospitals and clinics to register 7.3% CAGR during the forecast period 2022 to 2032
Start-up Scenario
Embolx, Embo Medical, IMBiotechnologies, Shape Memory Medical, Biosphere Medical, Microvension, are some of the start-ups in the embolotherapy market
- IMBiotechnologies is a manufacturer of embolotherapy products for the treatment of cancer. The product developed called Ekobi is delivered through a catheter into the blood vessels that feed a target tissue and selectively block the tissue’s blood supply. The target tissue is either destroyed or devitalized, resulting in a therapeutic benefit. Ekobi 500 microspheres slowly degrade and are completely eliminated from the body in 4-6 months. These microspheres are easily detected using minimally invasive ultrasound. This product can be used against lung cancer, kidney cancer, etc.
Competitive Landscape
Medtronic plc, Stryker Corporation, Johnson & Johnson, BTG plc, Cook Medical, Penumbra, Inc., Abbott Laboratories, Boston Scientific Corporation, Merit Medical Systems, Terumo Corporation are some of the key companies in the embolotherapy market.
Companies operating in the market have been focusing on innovations. There is an immense focus on offering more efficient solutions depending upon evolving needs of end users. The global embolotherapy market is considered fairly fragmented due to the presence of a numerous players. Besides this, collaborations have been a key strategy among market players as they aim at expanding regional footprint as well as their product portfolio.
Some of the recent developments from the market are :
- In June 2022 -Stryker, today the opening of its new research and development facility, Stryker’s Global Technology Centre (SGTC) , at the International Tech Park. The 150,000-square-foot facility will help accelerate innovation in India and globally, and further support the company’s mission to make healthcare better.
- In September 2021 - Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the company's Portico™ with FlexNav™ Transcatheter Aortic Valve Replacement (TAVR) system to treat people with symptomatic, severe aortic stenosis who are at high or extreme risk for open-heart surgery. With this latest TAVR advancement, Abbott continues to offer the industry's leading portfolio of structural heart solutions that include innovative, minimally invasive therapies to repair or replace diseased or damaged heart valves or close openings in the heart.
- In October 2022 - Biosense Webster, Inc., part of Johnson & Johnson MedTech, announced the European launch of the HELIOSTAR™ Balloon Ablation Catheter - the first radiofrequency balloon ablation catheter. The HELIOSTAR™ Balloon Ablation Catheter is indicated for use in catheterbased cardiac electrophysiological mapping (stimulating and recording) of the atria and, when used with a compatible multi-channel RF generator, for cardiac ablation.
Key Segments Covered in the Embolotherapy Market Industry Survey
-
By Product Type :
- Embolic Agents
- Microspheres
- Embolic coils
- Embolic Plug Systems
- Detachable Ballons
- Liquid Embolic Agents,
- others
- Support Devices
- Microcatheters
- Guidewires
- Embolic Agents
-
By Disease Indication :
- Cancer
- Liver Cancer
- Kidney Cancer
- Other Cancer
- Peripheral Vascular Disease
- Peripheral Vascular Disease
- Urological & Nephrological Disorder
- Gastrointestinal Disorder
- others
- Cancer
-
By Procedure :
- Transcatheter Arterial Embolization (TAE)
- Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT)
- Transarterial Chemoembolization (TACE)
-
By End-user :
- Hospitals& Clinics
- Ambulatory Surgical Centre
- Others
-
By Region :
- North America;
- Latin America;
- Europe
- South Asia
- East Asia
- Oceania
- MEA
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Market Background
- 4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032
- 5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Products
- 5.1. Embolic Agent
- 5.1.1. Microspheres
- 5.1.2. Embolic coils
- 5.1.3. Embolic Plug Systems
- 5.1.4. Detachable Balloons
- 5.1.5. Liquid Embolic Agents
- 5.1.6. Others
- 5.2. Support Devices
- 5.2.1. Microcatheters
- 5.2.2. Guidewires
- 5.1. Embolic Agent
- 6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Disease Indication
- 6.1. Cancer
- 6.1.1. Liver Cancer
- 6.1.2. Kidney Cancer
- 6.1.3. Other Cancers
- 6.2. Peripheral Vascular Disease
- 6.3. Neurological Disease
- 6.4. Urological & Nephrological Disorder
- 6.5. Gastrointestinal Disorder
- 6.6. Others
- 6.1. Cancer
- 7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Procedure
- 7.1. Transcatheter Arterial Embolization (TAE)
- 7.2. Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT)
- 7.3. Transarterial Chemoembolization (TACE)
- 8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User
- 8.1. Hospital & Clinic
- 8.2. Ambulatory Surgery Center
- 8.3. Others
- 9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
- 9.1. North America
- 9.2. Latin America
- 9.3. Europe
- 9.4. South Asia
- 9.5. East Asia
- 9.6. Oceania
- 9.7. MEA
- 10. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
- 11. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
- 12. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
- 13. South Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
- 14. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
- 15. Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
- 16. MEA Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
- 17. Key Countries Market Analysis
- 18. Market Structure Analysis
- 19. Competition Analysis
- 19.1. Medtronic plc
- 19.2. Stryker Corporation
- 19.3. Johnson & Johnson
- 19.4. BTG plc
- 19.5. Cook Medical
- 19.6. Penumbra, Inc.
- 19.7. Abbott Laboratories
- 19.8. Boston Scientific Corporation
- 19.9. Merit Medical Systems
- 19.10. Terumo Corporation
- 20. Assumptions & Acronyms Used
- 21. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Forecast by Region, 2017 to 2032
Table 02: Global Market Value (US$ Mn) Forecast by Products, 2017 to 2032
Table 03: Global Market Value (US$ Mn) Forecast by Disease Indication, 2017 to 2032
Table 04: Global Market Value (US$ Mn) Forecast by Procedure , 2017 to 2032
Table 05: Global Market Value (US$ Mn) Forecast by End User, 2017 to 2032
Table 06: North America Market Value (US$ Mn) Forecast by Country, 2017 to 2032
Table 07: North America Market Value (US$ Mn) Forecast by Products, 2017 to 2032
Table 08: North America Market Value (US$ Mn) Forecast by Disease Indication, 2017 to 2032
Table 09: North America Market Value (US$ Mn) Forecast by Procedure , 2017 to 2032
Table 10: North America Market Value (US$ Mn) Forecast by End User, 2017 to 2032
Table 11: Latin America Market Value (US$ Mn) Forecast by Country, 2017 to 2032
Table 12: Latin America Market Value (US$ Mn) Forecast by Products, 2017 to 2032
Table 13: Latin America Market Value (US$ Mn) Forecast by Disease Indication, 2017 to 2032
Table 14: Latin America Market Value (US$ Mn) Forecast by Procedure , 2017 to 2032
Table 15: Latin America Market Value (US$ Mn) Forecast by End User, 2017 to 2032
Table 16: Europe Market Value (US$ Mn) Forecast by Country, 2017 to 2032
Table 17: Europe Market Value (US$ Mn) Forecast by Products, 2017 to 2032
Table 18: Europe Market Value (US$ Mn) Forecast by Disease Indication, 2017 to 2032
Table 19: Europe Market Value (US$ Mn) Forecast by Procedure , 2017 to 2032
Table 20: Europe Market Value (US$ Mn) Forecast by End User, 2017 to 2032
Table 21: South Asia Market Value (US$ Mn) Forecast by Country, 2017 to 2032
Table 22: South Asia Market Value (US$ Mn) Forecast by Products, 2017 to 2032
Table 23: South Asia Market Value (US$ Mn) Forecast by Disease Indication, 2017 to 2032
Table 24: South Asia Market Value (US$ Mn) Forecast by Procedure , 2017 to 2032
Table 25: South Asia Market Value (US$ Mn) Forecast by End User, 2017 to 2032
Table 26: East Asia Market Value (US$ Mn) Forecast by Country, 2017 to 2032
Table 27: East Asia Market Value (US$ Mn) Forecast by Products, 2017 to 2032
Table 28: East Asia Market Value (US$ Mn) Forecast by Disease Indication, 2017 to 2032
Table 29: East Asia Market Value (US$ Mn) Forecast by Procedure , 2017 to 2032
Table 30: East Asia Market Value (US$ Mn) Forecast by End User, 2017 to 2032
Table 31: Oceania Market Value (US$ Mn) Forecast by Country, 2017 to 2032
Table 32: Oceania Market Value (US$ Mn) Forecast by Products, 2017 to 2032
Table 33: Oceania Market Value (US$ Mn) Forecast by Disease Indication, 2017 to 2032
Table 34: Oceania Market Value (US$ Mn) Forecast by Procedure , 2017 to 2032
Table 35: Oceania Market Value (US$ Mn) Forecast by End User, 2017 to 2032
Table 36: MEA Market Value (US$ Mn) Forecast by Country, 2017 to 2032
Table 37: MEA Market Value (US$ Mn) Forecast by Products, 2017 to 2032
Table 38: MEA Market Value (US$ Mn) Forecast by Disease Indication, 2017 to 2032
Table 39: MEA Market Value (US$ Mn) Forecast by Procedure , 2017 to 2032
Table 40: MEA Market Value (US$ Mn) Forecast by End User, 2017 to 2032
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) by Products, 2022 to 2032
Figure 02: Global Market Value (US$ Mn) by Disease Indication, 2022 to 2032
Figure 03: Global Market Value (US$ Mn) by Procedure , 2022 to 2032
Figure 04: Global Market Value (US$ Mn) by End User, 2022 to 2032
Figure 05: Global Market Value (US$ Mn) by Region, 2022 to 2032
Figure 06: Global Market Value (US$ Mn) Analysis by Region, 2017 to 2032
Figure 07: Global Market Value Share (%) and BPS Analysis by Region, 2022 to 2032
Figure 08: Global Market Y-o-Y Growth (%) Projections by Region, 2022 to 2032
Figure 09: Global Market Value (US$ Mn) Analysis by Products, 2017 to 2032
Figure 10: Global Market Value Share (%) and BPS Analysis by Products, 2022 to 2032
Figure 11: Global Market Y-o-Y Growth (%) Projections by Products, 2022 to 2032
Figure 12: Global Market Value (US$ Mn) Analysis by Disease Indication, 2017 to 2032
Figure 13: Global Market Value Share (%) and BPS Analysis by Disease Indication, 2022 to 2032
Figure 14: Global Market Y-o-Y Growth (%) Projections by Disease Indication, 2022 to 2032
Figure 15: Global Market Value (US$ Mn) Analysis by Procedure , 2017 to 2032
Figure 16: Global Market Value Share (%) and BPS Analysis by Procedure , 2022 to 2032
Figure 17: Global Market Y-o-Y Growth (%) Projections by Procedure , 2022 to 2032
Figure 18: Global Market Value (US$ Mn) Analysis by End User, 2017 to 2032
Figure 19: Global Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 20: Global Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 21: Global Market Attractiveness by Products, 2022 to 2032
Figure 22: Global Market Attractiveness by Disease Indication, 2022 to 2032
Figure 23: Global Market Attractiveness by Procedure , 2022 to 2032
Figure 24: Global Market Attractiveness by End User, 2022 to 2032
Figure 25: Global Market Attractiveness by Region, 2022 to 2032
Figure 26: North America Market Value (US$ Mn) by Products, 2022 to 2032
Figure 27: North America Market Value (US$ Mn) by Disease Indication, 2022 to 2032
Figure 28: North America Market Value (US$ Mn) by Procedure , 2022 to 2032
Figure 29: North America Market Value (US$ Mn) by End User, 2022 to 2032
Figure 30: North America Market Value (US$ Mn) by Country, 2022 to 2032
Figure 31: North America Market Value (US$ Mn) Analysis by Country, 2017 to 2032
Figure 32: North America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 33: North America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 34: North America Market Value (US$ Mn) Analysis by Products, 2017 to 2032
Figure 35: North America Market Value Share (%) and BPS Analysis by Products, 2022 to 2032
Figure 36: North America Market Y-o-Y Growth (%) Projections by Products, 2022 to 2032
Figure 37: North America Market Value (US$ Mn) Analysis by Disease Indication, 2017 to 2032
Figure 38: North America Market Value Share (%) and BPS Analysis by Disease Indication, 2022 to 2032
Figure 39: North America Market Y-o-Y Growth (%) Projections by Disease Indication, 2022 to 2032
Figure 40: North America Market Value (US$ Mn) Analysis by Procedure , 2017 to 2032
Figure 41: North America Market Value Share (%) and BPS Analysis by Procedure , 2022 to 2032
Figure 42: North America Market Y-o-Y Growth (%) Projections by Procedure , 2022 to 2032
Figure 43: North America Market Value (US$ Mn) Analysis by End User, 2017 to 2032
Figure 44: North America Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 45: North America Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 46: North America Market Attractiveness by Products, 2022 to 2032
Figure 47: North America Market Attractiveness by Disease Indication, 2022 to 2032
Figure 48: North America Market Attractiveness by Procedure , 2022 to 2032
Figure 49: North America Market Attractiveness by End User, 2022 to 2032
Figure 50: North America Market Attractiveness by Country, 2022 to 2032
Figure 51: Latin America Market Value (US$ Mn) by Products, 2022 to 2032
Figure 52: Latin America Market Value (US$ Mn) by Disease Indication, 2022 to 2032
Figure 53: Latin America Market Value (US$ Mn) by Procedure , 2022 to 2032
Figure 54: Latin America Market Value (US$ Mn) by End User, 2022 to 2032
Figure 55: Latin America Market Value (US$ Mn) by Country, 2022 to 2032
Figure 56: Latin America Market Value (US$ Mn) Analysis by Country, 2017 to 2032
Figure 57: Latin America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 58: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 59: Latin America Market Value (US$ Mn) Analysis by Products, 2017 to 2032
Figure 60: Latin America Market Value Share (%) and BPS Analysis by Products, 2022 to 2032
Figure 61: Latin America Market Y-o-Y Growth (%) Projections by Products, 2022 to 2032
Figure 62: Latin America Market Value (US$ Mn) Analysis by Disease Indication, 2017 to 2032
Figure 63: Latin America Market Value Share (%) and BPS Analysis by Disease Indication, 2022 to 2032
Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Disease Indication, 2022 to 2032
Figure 65: Latin America Market Value (US$ Mn) Analysis by Procedure , 2017 to 2032
Figure 66: Latin America Market Value Share (%) and BPS Analysis by Procedure , 2022 to 2032
Figure 67: Latin America Market Y-o-Y Growth (%) Projections by Procedure , 2022 to 2032
Figure 68: Latin America Market Value (US$ Mn) Analysis by End User, 2017 to 2032
Figure 69: Latin America Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 70: Latin America Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 71: Latin America Market Attractiveness by Products, 2022 to 2032
Figure 72: Latin America Market Attractiveness by Disease Indication, 2022 to 2032
Figure 73: Latin America Market Attractiveness by Procedure , 2022 to 2032
Figure 74: Latin America Market Attractiveness by End User, 2022 to 2032
Figure 75: Latin America Market Attractiveness by Country, 2022 to 2032
Figure 76: Europe Market Value (US$ Mn) by Products, 2022 to 2032
Figure 77: Europe Market Value (US$ Mn) by Disease Indication, 2022 to 2032
Figure 78: Europe Market Value (US$ Mn) by Procedure , 2022 to 2032
Figure 79: Europe Market Value (US$ Mn) by End User, 2022 to 2032
Figure 80: Europe Market Value (US$ Mn) by Country, 2022 to 2032
Figure 81: Europe Market Value (US$ Mn) Analysis by Country, 2017 to 2032
Figure 82: Europe Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 83: Europe Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 84: Europe Market Value (US$ Mn) Analysis by Products, 2017 to 2032
Figure 85: Europe Market Value Share (%) and BPS Analysis by Products, 2022 to 2032
Figure 86: Europe Market Y-o-Y Growth (%) Projections by Products, 2022 to 2032
Figure 87: Europe Market Value (US$ Mn) Analysis by Disease Indication, 2017 to 2032
Figure 88: Europe Market Value Share (%) and BPS Analysis by Disease Indication, 2022 to 2032
Figure 89: Europe Market Y-o-Y Growth (%) Projections by Disease Indication, 2022 to 2032
Figure 90: Europe Market Value (US$ Mn) Analysis by Procedure , 2017 to 2032
Figure 91: Europe Market Value Share (%) and BPS Analysis by Procedure , 2022 to 2032
Figure 92: Europe Market Y-o-Y Growth (%) Projections by Procedure , 2022 to 2032
Figure 93: Europe Market Value (US$ Mn) Analysis by End User, 2017 to 2032
Figure 94: Europe Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 95: Europe Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 96: Europe Market Attractiveness by Products, 2022 to 2032
Figure 97: Europe Market Attractiveness by Disease Indication, 2022 to 2032
Figure 98: Europe Market Attractiveness by Procedure , 2022 to 2032
Figure 99: Europe Market Attractiveness by End User, 2022 to 2032
Figure 100: Europe Market Attractiveness by Country, 2022 to 2032
Figure 101: South Asia Market Value (US$ Mn) by Products, 2022 to 2032
Figure 102: South Asia Market Value (US$ Mn) by Disease Indication, 2022 to 2032
Figure 103: South Asia Market Value (US$ Mn) by Procedure , 2022 to 2032
Figure 104: South Asia Market Value (US$ Mn) by End User, 2022 to 2032
Figure 105: South Asia Market Value (US$ Mn) by Country, 2022 to 2032
Figure 106: South Asia Market Value (US$ Mn) Analysis by Country, 2017 to 2032
Figure 107: South Asia Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 108: South Asia Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 109: South Asia Market Value (US$ Mn) Analysis by Products, 2017 to 2032
Figure 110: South Asia Market Value Share (%) and BPS Analysis by Products, 2022 to 2032
Figure 111: South Asia Market Y-o-Y Growth (%) Projections by Products, 2022 to 2032
Figure 112: South Asia Market Value (US$ Mn) Analysis by Disease Indication, 2017 to 2032
Figure 113: South Asia Market Value Share (%) and BPS Analysis by Disease Indication, 2022 to 2032
Figure 114: South Asia Market Y-o-Y Growth (%) Projections by Disease Indication, 2022 to 2032
Figure 115: South Asia Market Value (US$ Mn) Analysis by Procedure , 2017 to 2032
Figure 116: South Asia Market Value Share (%) and BPS Analysis by Procedure , 2022 to 2032
Figure 117: South Asia Market Y-o-Y Growth (%) Projections by Procedure , 2022 to 2032
Figure 118: South Asia Market Value (US$ Mn) Analysis by End User, 2017 to 2032
Figure 119: South Asia Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 120: South Asia Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 121: South Asia Market Attractiveness by Products, 2022 to 2032
Figure 122: South Asia Market Attractiveness by Disease Indication, 2022 to 2032
Figure 123: South Asia Market Attractiveness by Procedure , 2022 to 2032
Figure 124: South Asia Market Attractiveness by End User, 2022 to 2032
Figure 125: South Asia Market Attractiveness by Country, 2022 to 2032
Figure 126: East Asia Market Value (US$ Mn) by Products, 2022 to 2032
Figure 127: East Asia Market Value (US$ Mn) by Disease Indication, 2022 to 2032
Figure 128: East Asia Market Value (US$ Mn) by Procedure , 2022 to 2032
Figure 129: East Asia Market Value (US$ Mn) by End User, 2022 to 2032
Figure 130: East Asia Market Value (US$ Mn) by Country, 2022 to 2032
Figure 131: East Asia Market Value (US$ Mn) Analysis by Country, 2017 to 2032
Figure 132: East Asia Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 133: East Asia Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 134: East Asia Market Value (US$ Mn) Analysis by Products, 2017 to 2032
Figure 135: East Asia Market Value Share (%) and BPS Analysis by Products, 2022 to 2032
Figure 136: East Asia Market Y-o-Y Growth (%) Projections by Products, 2022 to 2032
Figure 137: East Asia Market Value (US$ Mn) Analysis by Disease Indication, 2017 to 2032
Figure 138: East Asia Market Value Share (%) and BPS Analysis by Disease Indication, 2022 to 2032
Figure 139: East Asia Market Y-o-Y Growth (%) Projections by Disease Indication, 2022 to 2032
Figure 140: East Asia Market Value (US$ Mn) Analysis by Procedure , 2017 to 2032
Figure 141: East Asia Market Value Share (%) and BPS Analysis by Procedure , 2022 to 2032
Figure 142: East Asia Market Y-o-Y Growth (%) Projections by Procedure , 2022 to 2032
Figure 143: East Asia Market Value (US$ Mn) Analysis by End User, 2017 to 2032
Figure 144: East Asia Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 145: East Asia Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 146: East Asia Market Attractiveness by Products, 2022 to 2032
Figure 147: East Asia Market Attractiveness by Disease Indication, 2022 to 2032
Figure 148: East Asia Market Attractiveness by Procedure , 2022 to 2032
Figure 149: East Asia Market Attractiveness by End User, 2022 to 2032
Figure 150: East Asia Market Attractiveness by Country, 2022 to 2032
Figure 151: Oceania Market Value (US$ Mn) by Products, 2022 to 2032
Figure 152: Oceania Market Value (US$ Mn) by Disease Indication, 2022 to 2032
Figure 153: Oceania Market Value (US$ Mn) by Procedure , 2022 to 2032
Figure 154: Oceania Market Value (US$ Mn) by End User, 2022 to 2032
Figure 155: Oceania Market Value (US$ Mn) by Country, 2022 to 2032
Figure 156: Oceania Market Value (US$ Mn) Analysis by Country, 2017 to 2032
Figure 157: Oceania Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 158: Oceania Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 159: Oceania Market Value (US$ Mn) Analysis by Products, 2017 to 2032
Figure 160: Oceania Market Value Share (%) and BPS Analysis by Products, 2022 to 2032
Figure 161: Oceania Market Y-o-Y Growth (%) Projections by Products, 2022 to 2032
Figure 162: Oceania Market Value (US$ Mn) Analysis by Disease Indication, 2017 to 2032
Figure 163: Oceania Market Value Share (%) and BPS Analysis by Disease Indication, 2022 to 2032
Figure 164: Oceania Market Y-o-Y Growth (%) Projections by Disease Indication, 2022 to 2032
Figure 165: Oceania Market Value (US$ Mn) Analysis by Procedure , 2017 to 2032
Figure 166: Oceania Market Value Share (%) and BPS Analysis by Procedure , 2022 to 2032
Figure 167: Oceania Market Y-o-Y Growth (%) Projections by Procedure , 2022 to 2032
Figure 168: Oceania Market Value (US$ Mn) Analysis by End User, 2017 to 2032
Figure 169: Oceania Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 170: Oceania Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 171: Oceania Market Attractiveness by Products, 2022 to 2032
Figure 172: Oceania Market Attractiveness by Disease Indication, 2022 to 2032
Figure 173: Oceania Market Attractiveness by Procedure , 2022 to 2032
Figure 174: Oceania Market Attractiveness by End User, 2022 to 2032
Figure 175: Oceania Market Attractiveness by Country, 2022 to 2032
Figure 176: MEA Market Value (US$ Mn) by Products, 2022 to 2032
Figure 177: MEA Market Value (US$ Mn) by Disease Indication, 2022 to 2032
Figure 178: MEA Market Value (US$ Mn) by Procedure , 2022 to 2032
Figure 179: MEA Market Value (US$ Mn) by End User, 2022 to 2032
Figure 180: MEA Market Value (US$ Mn) by Country, 2022 to 2032
Figure 181: MEA Market Value (US$ Mn) Analysis by Country, 2017 to 2032
Figure 182: MEA Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 183: MEA Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 184: MEA Market Value (US$ Mn) Analysis by Products, 2017 to 2032
Figure 185: MEA Market Value Share (%) and BPS Analysis by Products, 2022 to 2032
Figure 186: MEA Market Y-o-Y Growth (%) Projections by Products, 2022 to 2032
Figure 187: MEA Market Value (US$ Mn) Analysis by Disease Indication, 2017 to 2032
Figure 188: MEA Market Value Share (%) and BPS Analysis by Disease Indication, 2022 to 2032
Figure 189: MEA Market Y-o-Y Growth (%) Projections by Disease Indication, 2022 to 2032
Figure 190: MEA Market Value (US$ Mn) Analysis by Procedure , 2017 to 2032
Figure 191: MEA Market Value Share (%) and BPS Analysis by Procedure , 2022 to 2032
Figure 192: MEA Market Y-o-Y Growth (%) Projections by Procedure , 2022 to 2032
Figure 193: MEA Market Value (US$ Mn) Analysis by End User, 2017 to 2032
Figure 194: MEA Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 195: MEA Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 196: MEA Market Attractiveness by Products, 2022 to 2032
Figure 197: MEA Market Attractiveness by Disease Indication, 2022 to 2032
Figure 198: MEA Market Attractiveness by Procedure , 2022 to 2032
Figure 199: MEA Market Attractiveness by End User, 2022 to 2032
Figure 200: MEA Market Attractiveness by Country, 2022 to 2032
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the expected valuation of the embolotherapy market?
The global embolotherapy market is likely to reach a valuation of US$ 3,545.5 Million by the end of 2022.
What will be the global embolotherapy market revenue total by 2032?
By the end of 2032, the global market for embolotherapy market is predicted to reach a valuation of US$ 7,942.8 Million.
What are the future prospects for embolotherapy market sales?
Sales of embolotherapy market are likely to expand at 8.4% CAGR through 2032.
Which are the top 5 countries driving demand for embolotherapy market?
The U.S., Canada, Japan, China, and Germany are expected to drive most of the demand for embolotherapy Market.
Who are the key players in the embolotherapy market?
Medtronic plc, Stryker Corporation, Johnson & Johnson, BTG plc, Cook Medical, Penumbra, Inc., Abbott Laboratories are some of the key players in global embolotherapy Market.
Embolotherapy Market